Recombinant human epoetin beta in the treatment of renal anemia

Author： Del Vecchio Lucia Cavalli Andrea Pozzoni Pietro Locatelli Francesco

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.1, 2008-01, pp. : 91-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite

Evolving Treatment Strategies for Anaemia in Cancer: Experience with Epoetin Beta

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Anaemia Management Strategies: Optimising Treatment Using Epoetin Beta (NeoRecormon^®)

Oncology, Vol. 69, Iss. 2, 2005-10 ,pp. : 8-16

Karger

Access to resources Recommend Favorite